Cardiac Lipotoxicity: Molecular Pathways and Therapeutic Implications Konstantinos DrosatosP. Christian Schulze Pathophysiology: Neuroendocrine, Vascular, and Metabolic Factors (SD Katz, Section Editor) 19 March 2013 Pages: 109 - 121
Platelet Activating Factor in Heart Failure: Potential Role in Disease Progression and Novel Target for Therapy Paraskevi DetopoulouTzortzis NomikosSmaragdi Antonopoulou Pathophysiology: Neuroendocrine, Vascular, and Metabolic Factors (S.D. Katz, Section Editor) 07 February 2013 Pages: 122 - 129
High-Intensity Aerobic Interval Exercise in Chronic Heart Failure Philippe MeyerMathieu GaydaAnil Nigam Pathophysiology: Neuroendocrine, Vascular, and Metabolic Factors (S.D. Katz, Section Editor) 10 February 2013 Pages: 130 - 138
Chemohypersensitivity and Autonomic Modulation of Venous Capacitance in the Pathophysiology of Acute Decompensated Heart Failure Amy E. BurchellPaul A. SobotkaMark E. Dunlap Pathophysiology: Neuroendocrine, Vascular, and Metabolic Factors (SD Katz, Section Editor) 16 March 2013 Pages: 139 - 146
Preoperative Cardiac Risk Assessment for Noncardiac Surgery in Patients with Heart Failure Jenica UpshawMichael S. Kiernan Management of Heart Failure (Te Meyer, Section Editor) 27 March 2013 Pages: 147 - 156
Treating Hypertension in Patients with Left Ventricular Dysfunction: Hitting the Fairway and Avoiding the Rough Samuel W. JoffeRobert A. Phillips Management of Heart Failure (TE Meyer, Section Editor) 09 April 2013 Pages: 157 - 164
Current Status of Cell-Based Therapy for Heart Failure Philipp JakobUlf Landmesser Management of Heart Failure (TE Meyer, Section Editor) 19 March 2013 Pages: 165 - 176
Defining the Role for Percutaneous Mechanical Circulatory Support Devices for Medically Refractory Heart Failure Navin K. KapurMarwan F. Jumean Management of Heart Failure (T.E. Meyer, Section Editor) 07 February 2013 Pages: 177 - 184